Yadav, Punit
Cockwell, Paul
Cook, Mark
Pinney, Jennifer
Giles, Hannah
Aung, Yu Sandar
Cairns, David
Owen, Roger G.
Davies, Faith E.
Jackson, Graham H.
Child, J. Anthony
Morgan, Gareth J.
Drayson, Mark T.
Funding for this research was provided by:
Medical Research Council (G0100132)
Article History
Received: 23 January 2018
Accepted: 25 June 2018
First Online: 13 July 2018
Ethics approval and consent to participate
: MRC Myeloma IX trial had a multicentre research ethics committee and local ethics committee’s approval and all patients gave written informed consent in accordance to the Declaration of Helsinki (International Standard Randomised Controlled Trial Number 68454111).
: Not applicable.
: University of Birmingham and MTD own shares in Abingdon Health that manufactures immunodiagnostic tests to quantify FLC levels. PC is a medical advisor to The Binding Site that produces the Freelite assay. The remaining authors have no competing financial interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.